Dimension and Bayer join forces to de...

Dimension and Bayer join forces to develop gene therapy for Hemophilia A

There are 1 comment on the PE Hub story from Jun 23, 2014, titled Dimension and Bayer join forces to develop gene therapy for Hemophilia A. In it, PE Hub reports that:

Dimension Therapeutics has entered into a collaboration with Bayer HealthCare for the development and commercialization of a novel gene therapy for the treatment of hemophilia A. Dimension has been funded by Fidelity Biosciences and OrbiMed Advisors .

Join the discussion below, or Read more at PE Hub.

Sanjeev Sharma

United States

#1 Jun 23, 2014
Greetings to Dimension and Bayer for their fresh start.

I wish both of you will get success in this GENE therapy and helps lakhs of patient who daily pray for long term treatment.

Wish you a successful soon.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Manufacturing Discussions

Title Updated Last By Comments
News Eaton, US Department of Energy to Enhance Colla... Jan 15 Solarman 1
News IAC's future in limbo (Jun '07) Dec '17 dylan f 69
News Professors worldwide boycott University of Roch... Nov '17 Mrs L 4
New Andon software Nov '17 nateandon 1
News Goodyear Tire recalls Eagle RS-A 18" TIRES (Feb '09) Oct '17 Daniel 14
Can manufactures use W.O.T.C. ? Oct '17 Larry Potter 1
headstone manufacturers Oct '17 Andymolly 1
More from around the web